We are live on ! Find out more
PIP

Palisades Investment Partners Portfolio holdings

AUM $352M
1-Year Est. Return 76.79%
This Fund
S&P 500
This Quarter Est. Return
+11.31%
1 Year Est. Return
+76.79%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$27.8M
Cap. Flow
+$12.9M
Cap. Flow %
5.61%
Top 10 Hldgs %
54.83%
Holding
43
New
3
Increased
37
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$4.57M
2
INOD icon
Innodata
INOD
+$2.21M
3
TMDX icon
Transmedics
TMDX
+$1.39M
4
DCTH icon
Delcath Systems
DCTH
+$1.3M
5
SPXC icon
SPX Corp
SPXC
+$898K

Top Sells

Rank Stock Value
1
FROG icon
JFrog
FROG
+$4.6M
2
POWL icon
Powell Industries
POWL
+$2.15M
3
VTSI icon
VirTra
VTSI
+$1.02M

Sector Composition

Rank Sector Weight
1 Industrials 31.75%
2 Healthcare 26.43%
3 Technology 17.24%
4 Consumer Discretionary 11.64%
5 Financials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMDX icon
1
Transmedics
TMDX
$2.91B
$23.4M 10.17%
148,785
+9,048
+6% +$1.39M
SPXC icon
2
SPX Corp
SPXC
$10.8B
$16.3M 7.08%
101,988
+5,953
+6% +$898K
STRL icon
3
Sterling Infrastructure
STRL
$16.7B
$15.1M 6.58%
104,256
+6,106
+6% +$726K
MOD icon
4
Modine Manufacturing
MOD
$10.4B
$13.5M 5.86%
101,372
+5,851
+6% +$647K
MMYT icon
5
MakeMyTrip
MMYT
$5.64B
$10.9M 4.76%
117,766
+6,812
+6% +$642K
AVAV icon
6
AeroVironment
AVAV
$9.45B
$10.7M 4.66%
53,361
+3,284
+7% +$591K
UFPT icon
7
UFP Technologies
UFPT
$2.43B
$10.1M 4.41%
31,982
+1,812
+6% +$578K
SPSC icon
8
SPS Commerce
SPSC
$2.64B
$8.8M 3.83%
45,304
+2,773
+7% +$544K
NSSC icon
9
Napco Security Technologies
NSSC
$1.48B
$8.68M 3.78%
214,631
+12,783
+6% +$627K
BLBD icon
10
Blue Bird Corp
BLBD
$2.18B
$8.5M 3.7%
177,278
+11,927
+7% +$589K
INTA icon
11
Intapp
INTA
$2.91B
$7.22M 3.14%
150,890
+8,757
+6% +$353K
ADMA icon
12
ADMA Biologics
ADMA
$2.22B
$6.98M 3.04%
349,005
+19,984
+6% +$311K
BMI icon
13
Badger Meter
BMI
$4.03B
$6.79M 2.96%
31,083
+1,803
+6% +$361K
KRYS icon
14
Krystal Biotech
KRYS
$9.66B
$6.74M 2.94%
37,043
+2,356
+7% +$454K
INOD icon
15
Innodata
INOD
$2.04B
$5.83M 2.54%
347,558
+130,991
+60% +$2.21M
MEDP icon
16
Medpace
MEDP
$16.5B
$4.87M 2.12%
14,581
+889
+6% +$338K
MC icon
17
Moelis & Co
MC
$4.94B
$4.8M 2.09%
70,015
+4,147
+6% +$268K
CAMT icon
18
Camtek
CAMT
$7.25B
$4.7M 2.05%
58,920
+3,352
+6% +$327K
MSA icon
19
Mine Safety
MSA
$7.49B
$4.55M 1.98%
25,657
+1,557
+6% +$283K
SWTX
20
DELISTED
SpringWorks Therapeutics
SWTX
$3.92M 1.71%
+122,291
New +$4.57M
ONTO icon
21
Onto Innovation
ONTO
$15.3B
$3.87M 1.68%
18,641
+1,120
+6% +$226K
FFBC icon
22
First Financial Bancorp
FFBC
$3.53B
$3.4M 1.48%
134,835
+8,012
+6% +$201K
ARDX icon
23
Ardelyx
ARDX
$988M
$3.33M 1.45%
483,349
+30,778
+7% +$182K
FISI icon
24
Financial Institutions
FISI
$821M
$3.23M 1.41%
126,775
+7,388
+6% +$176K
OTTR icon
25
Otter Tail
OTTR
$3.94B
$3.21M 1.4%
41,098
+2,512
+7% +$217K
1
2

Similar funds

ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
AW
Alaethes Wealth Glenbrook, Nevada $351M AUM 22.79% 1-Year Est. Return
PIC
PCJ Investment Counsel Toronto, Ontario, Canada $352M AUM 68.32% 1-Year Est. Return
EC
Elmind Capital New York $352M AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SMC
Spider Management Company Richmond, Virginia $351M AUM 18.35% 1-Year Est. Return
BL
BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Palisades Investment Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Palisades Investment Partners held 43 positions worth $230M, up 14% from $202M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Palisades Investment Partners deployed $12.9M of net new capital in Q3 2024, opening 3 new positions and adding to 37 existing holdings. Its largest new stake was SpringWorks Therapeutics: 122,291 shares worth $3.92M.

By sector, the portfolio is most concentrated in Industrials at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the most notable exit was JFrog, an estimated $4.6M sold.

  • Palisades Investment Partners's largest Q3 2024 buy was SpringWorks Therapeutics: 122,291 shares worth $3.92M.
  • Palisades Investment Partners added most to Innodata in Q3 2024, an estimated $2.21M increase.
  • Palisades Investment Partners fully exited JFrog in Q3 2024, selling an estimated $4.6M.
  • Palisades Investment Partners's ten largest holdings make up 55% of its $230M portfolio in Q3 2024.
  • Palisades Investment Partners opened 3 new positions and closed 3 in Q3 2024.
  • Palisades Investment Partners's portfolio value rose 14% quarter-over-quarter to $230M.

Based on Palisades Investment Partners's 13F filing for Q3 2024, filed 18 Feb 2025.